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Abstract
Background: Acquired uterine arteriovenous malformation (AVM) is a rare condition
due to traumatic episodes in cesarean section. The patient can suffer from life-
threatening hemorrhage or recurrent vaginal bleeding. Establishing this diagnosis is
difficult, often misdiagnosed due to lack of information and number of cases. Trans-
Arterial Embolization (TAE) procedure is rarely performed in our center. All of the
cases were found with history of massive bleeding and diagnosed lately after recurrent
bleeding history. Even though promising, one of our cases failed to be managed with
TAE. It is important to diagnose early symptoms of AVM in order to prevent the life
threatening event.
Case presentation: In these case series, four cases of AVMs after cesarean procedures
will be reviewed. One could be diagnosed in less than a month but the other three took
several months. The symptom of vaginal bleeding might occur a few weeks after the
procedure is done, andmost patients need transfusion and hospitalization. Three out of
four patients were initially sent to the hospital in order to recover from shock condition,
and one patient was sent for a diagnostic procedure. AVMs diagnostic was established
with ultrasound with or without angiography. Three of our cases were succeeded by
performing TAE procedure without further severe vaginal bleeding. One case failed to
be treated with embolization and had to proceed with hysterectomy.
Conclusion: AVM should be considered early-on in patient with abnormal uterine
bleeding and history of cesarean section. Embolization is still the first-choice treatment
of AVMs, otherwise definitive treatment is hysterectomy in a patient without fertility
need, or impossible to perform TAE.
Key words: Trans-arterial embolization, Acquired uterine arteriovenous malformation,
Cesarean section.
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1. Introduction
Arteriovenous malformation (AVM) is a rare con-
dition complicating procedures such as cesarean
section, hysteroscopy, or curettage. Cesarean sec-
tion places second in leading clinical history asso-
ciated with AVMs (1). The incidence and prevalence
is difficult to determine, only some respond tomed-
ical treatment and several remain undiagnosed (2).
The patient can suffer from life-threatening hemor-
rhage or recurrent vaginal bleeding. Misdiagnosis
is commonly found due to lack of information and a
few numbers of cases. The choice of management
of this patient varies from hormonal treatment,
open surgical, or minimally invasive such TAE (1). In
this report, we present our experience in managing
four cases of AVMs, including the undiagnosed




A 35–yr-old woman, parity 3, came with recur-
rent vaginal bleeding with a history of cesarean
section due to preeclampsia 25 days ago. She
had a history of two-time cesarean section due
to hypertension in pregnancy. She used pills and
progestin injection for controlling the pregnancy.
She didn’t smoke and no one in her family had
the same problem. She experienced two times
hypovolemic shock and hemoglobin level was 3.9
g/dl. She had packed red cell (PRC) transfusion
and was able to reach hemoglobin level 10.5 g/dl.
In the first episode of shock, the gynecologist
didn’t find abnormality. Suspicion of AVM was
established in the second examination. She was
referred to the tertiary hospital for further exami-
nation. Right hematoma of 13×33 mm was found
connected with right uterine artery on the ultra-
sound examination corresponding to AVM (Figure
1A). The patient was then referred to vascular
surgery department where she underwent Multi-
Slice Computed Tomography (MSCT) angiography,
and hyper vascular pattern was discovered from
the right uterine artery (Figure 1B). Embolization
was conducted after stabilization. Guiding wire was
inserted from femoral artery to external iliac artery,
common iliac artery, and aorta. Digital subtraction
angiography (DSA) was systematically performed
from the aorta to the iliac artery. Aneurysm was
discovered originating from right uterine artery
(Figure 1C). Polyvinyl Alcohol (PVA) embolization
was then performed and gel-foam with coil. Micro-
catheter was inserted selectively to one of the
uterine artery branch until it reached the aneurysm
followed by coil insertion. Diagnostic catheter was
then placed at the internal iliac artery and contrast
was administered thereafter, no aneurism nor other
malformation was found (Figure 1D).
Five days after TAE, she had another vaginal
bleeding and she underwent hysterectomy.
2.2. Case 2
A 27-year-old woman came with profuse vaginal
bleeding with a history of cesarean section 60
days before admission due to non-reassuring fetal
heart pattern. She didn’t use any contraception.
She had no metabolic disease and never took
any routine medication. She didn’t smoke and
no one in her family had the same complaint.
She started to experience bleeding a week after
the procedure was done. Some episodes were
just spotting but some episodes were more like
menstrual blood. Once she got profuse vaginal
bleeding and blood transfusion with hemoglobin
level (6 gr/dl). She was planned for tertiary hospital
referral. Unfortunately, another attack of bleeding
happened that also required hospitalization and
blood transfusion. From Doppler study, new vascu-
larization was seen on the right area of cesarean
scar with vessel enlargement corresponding to
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aneurysm or vascular malformation (Figure 2A).
From the CT Angiograph, new lobulated oval lesion
was visible after the administration of contrast sized
0.67×0.47×0.75 cm, originating from distal branch
of right uterine artery corresponding to right uterine
artery aneurysm (Figure 2B). Catheter was placed
in the right iliac artery and aneurism was proved
originating from the ascending branch of right
uterine artery (Figure 2C). By using micro-catheter,
selective right uterine artery catheterization was
performed. Aneurysm was surrounded by hyper-
vascularization derived from arterial branches.
Embolization was performed using PVA 710–1000
microns. There was no aneurysm nor hypervas-
cularization was seen after the procedure (Figure
2D). She had no vaginal bleeding history after
procedure.
2.3. Case 3
An 18-year-old woman came to hospital with
chief complain of vaginal bleeding with a history of
cesarean section 49 days before admission due to
premature rupture of membrane. She never took
any medication for systemic disease and never
had the same vaginal bleeding before pregnancy.
She wasn’t a smoker and no one in her family
had the same complaint. She didn’t take any
birth-controlling pills or injection. The first vaginal
bleeding happened a week after cesarean section
without any abnormality being found. Recurrent
bleeding happened and PRC transfusion was
administered due to severe anemic condition with
the lowest hemoglobin being 4 gr/dl a week later.
Another episode of vaginal bleeding resulted in
lowering hemoglobin to 7.72 g/dl and caused an
emergency referral to our center. From transvaginal
ultrasound examination, at the left area of cesarean
scar, hematoma was seen in a non-homogenous
area. It was connected to the left uterine artery
branch, then diagnosed as AVMs and planned for
TAE (Figure 3A). Sheath 5F on left common femoral
artery was introduced. The end of catheter was
placed on distal left internal iliac artery. Saccular
dilatation of left uterine artery was found with sign
of extravasation of the artery, and also hypervas-
cularization and hypertrophy of left uterine artery
(Figure 3B). Embolization was performed on the left
uterine artery using PVA and gel-foam. There was
no aneurysm on the post embolization (Figure 3 C).
2.4. Case 4
A 32-year-old woman, parity 2 post-cesarean
section 4 months ago due to placenta previa came
with hypovolemic shock due to abnormal uterine
bleeding. She had no experience of vaginal bleed-
ing before or during pregnancy. The first preg-
nancy was spontaneous delivery. She took hor-
monal pills for birth controlling. She didn’t smoke
and no one in her family had the same complain.
She had two previous vaginal bleeding with unre-
markable gynecology and ultrasound examination.
Hemoglobin level was 4.2 g/dl. She was referred
to tertiary hospital for further evaluation. There
was AVM at the area of left cesarean scar (Figure
4A) and hence planned for TAE. The catheter was
inserted at the left iliac artery. It was seen that
the right uterine artery was normal and found
AVM at the branch of left uterine artery (Figure
4B) continued with the selective catheterization.
There was no AVMs after the procedure nor a
history of bleeding on policlinic follow-up (Figure
4C). Summary of four cases can be seen in Table I.
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Table I: Clinical summary of four cases of AVMs after caesarean section treated with TAE.
Case 1 Case 2 Case 3 Case 4
Age (yr) 35 27 18 32
Parity P3 P1 P1 P2
History of Caesarean
Section






25 60 49 131
AVM Side Right Right Left Left
Initial Hemoglobin
(g/dl)
3.9 7.6 7.72 4.2
History of Transfusion Yes Yes Yes Yes
Outcome Recurrent bleeding 30
days after TAE and
underwent
hysterectomy
No history of Abnormal
Uterine Bleeding
No history of Abnormal
Uterine Bleeding
No history of Abnormal
Uterine Bleeding
Note: AVM: Arteriovenous Malformation; P: Parity; and PPROM: Preterm Premature Rupture of Membranes.
Figure 1: (A) Doppler study showed hematoma connected with right uterine artery; (B) Hyper vascular pattern originated from
right uterine artery; (C) Aneurism originated from right uterine artery pre-TAE; and (D) Post micro-coil insertion.
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Figure 2: (A) New vascularization on the cesarean scar with vessel enlargement; (B) Lobulated oval lesion on CT Angiography;
(C) Aneurism at the right ascending uterine artery; and (D) TAE procedure found that there were no aneurism and
hypervascularization.
Figure 3: (A) Hematoma at left adnexa connected to left uterine artery; (B) Saccular dilatation of left uterine artery with sign of
extravasation of the artery. (C) Embolization on left uterine artery using PVA and gel-foam.
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Figure 4: (A) AVM at left cesarean scar. (B) AVM seen at the branch of left uterine artery continued with the selective
catheterization. (C) TAE procedure found no AVMs.
3. Discussion
AVM is a rare condition about 1–2% as complica-
tion of postpartum and consequence of increased
cesarean deliveries, with symptom of vaginal or
intra-peritoneal bleeding (3, 4). The diagnosis
is difficult, often misdiagnosis with retained pla-
centa. The cause of acquired AVMs is traumatic
episode of uterine artery during cesarean section
or myomectomy. Sometimes, infection contributes
to the development of AVM (5). Also, the AVMs
were reported as the results of cesarean scar
pregnancy, conservative accrete treatment, and
laparoscopic instrumentation of the uterine (6–8).
There was no specific technique or cesarean indi-
cation that caused the AVMs directly in literature
findings, also in our case the indications in four
cases varies.
The patient usually comes with postpartum
hemorrhage after cesarean section. In this report,
we learned that initially all of the cases were
diagnosed incorrectly. The episode was commonly
acute and found in hypovolemic shock that may
bring the patient in life-threatening condition and
increased rate of transfusion. The vaginal bleeding
symptom came few weeks after the procedures
and most of the patients need transfusion and
being hospitalized. Three of four in our cases were
sent after stabilization in other hospital with a
history of shock condition and sent for diagnostic
procedure. Some of them also got hormonal treat-
ment in some cases for abnormal bleeding man-
agement and reported lighter menstrual bleeding
(5).
Because clinical finding included only bleeding,
the ultrasound and angiography have important
role in diagnostic AVMs (3, 9). The gray-scale
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ultrasound examination is common but unable
to conclude any AVM. Our patient was already
examined before and the physician didnot find
any pathology. The doppler study is the main
screening tool in AVM. The ultrasound result of
AVM is not specific for retained placenta or AVM
but a hypo-echoic cystic or tubuliform area within
myometrium and bidirectional high-velocity- and
low-resistance blood flow increased suspicion of
AVM and needed CT angiography as a gold
standard (4, 10–12). MRI is able to diagnose the
AVMs with voluminous uterus, ill define mass,
and focal or diffuse interruption zone (12). CT
angiography can show if there is any extension to
the extra uterine or involvement or feeding artery,
so that every vascular malformation can be seen
(13).
An asymptomatic AVM can be treated with
expectant management. When there are repeated
symptoms, the traditional management, hysterec-
tomy, or artery ligation can be chosen (14, 15).
Some case reports already proposed hormonal
treatment in managing the AVMs. The origin of the
AVMs in pregnancy may correlate with estrogen,
vascular endothelial growth hormone, or another
hormone in pregnancy. Based on that hypothesis,
the gonadotrophin agonist was given by the down-
regulated estrogen mechanism (16). Gonadotropin-
releasing hormone was reported reducing the size
of AVM (17). Danazol and progestin can decrease
the bleeding (18). The intrauterine hormonal device
is also able to decrease the amount of blood loss,
but the expulsion of device is also reported (5). In
our cases, we preferred using surgery technique
TAE due to the patients’ history of acute bleeding,
and the first choice in managing AVMwas selective
embolization.
Three of our cases were succeeded with TAE
procedure without any severe vaginal bleeding
reported. One patient got another bleeding after
TAE procedure. The success rate of TAE in resolu-
tion of the lesion is about 85%. The others needed
another surgical procedures, repeated TAE, laparo-
scopic approach, or hysterectomy (1). Not only as
a definitive treatment, but also hysterectomy is a
choice when the facility of TAE is absent and for the
patient who doesn’t desire fertility. Rarely, clinical
events after TAE are amenorrhea and menopausal
symptom. In general, TAE procedures not specifi-
cally for AVMs found there was no differences of
ovarian function (19).
We only had four cases in five years’ period. This
shows that early diagnostic and treatment of AVM
are far from ideal. Also the diagnostic procedures
were different from each other. We are very far
frommaking a standardized management because
of the limitations of the case and facilities. But
reporting this, we move forward and encourage
to preserve uterine function by TAE in developing
countries.
As a conclusion, artery venous malformation is
a consequences of increased cesarean delivery.
The diagnostic isn’t always easy but has to be
considered in patient with history of cesarean sec-
tion. Embolization is still the first choice of AVMs,
otherwise definitive treatment is hysterectomy in
patient without fertility needs or it is impossible to
perform TAE.
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